8.65
price down icon2.15%   -0.19
after-market Handel nachbörslich: 8.64 -0.010 -0.12%
loading

Valneva Se Adr Aktie (VALN) Neueste Nachrichten

pulisher
Sep 04, 2025

VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Sep 04, 2025
pulisher
Sep 04, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Investors to Inquire about Securities Investigation - ACCESS Newswire

Sep 04, 2025
pulisher
Sep 03, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Investors to Reach Out - ACCESS Newswire

Sep 03, 2025
pulisher
Aug 28, 2025

Valneva announces U.S. FDA’s decision to suspend license of IXCHIQ - MSN

Aug 28, 2025
pulisher
Aug 27, 2025

Valneva selloff on FDA suspension overdone, says H.C. Wainwright - MSN

Aug 27, 2025
pulisher
Aug 27, 2025

Valneva SE ADR: Rising -26.86% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

Aug 27, 2025
pulisher
Aug 26, 2025

Valneva price target lowered to $14 from $18 at Jefferies - MSN

Aug 26, 2025
pulisher
Aug 25, 2025

Jefferies lowers Valneva stock price target to $14 on FDA suspension - Investing.com

Aug 25, 2025
pulisher
Aug 25, 2025

Valneva stock tumbles as FDA suspends license for IXCHIQ vaccine By Investing.com - Investing.com South Africa

Aug 25, 2025
pulisher
Aug 25, 2025

Valneva stock tumbles as FDA suspends license for IXCHIQ vaccine - Investing.com

Aug 25, 2025
pulisher
Aug 25, 2025

Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S. - GlobeNewswire Inc.

Aug 25, 2025
pulisher
Aug 24, 2025

Valneva (NASDAQ:VALN) Shares Gap Up – Still a Buy? - Defense World

Aug 24, 2025
pulisher
Aug 22, 2025

HC Wainwright Estimates Valneva’s Q3 Earnings (NASDAQ:VALN) - Defense World

Aug 22, 2025
pulisher
Aug 20, 2025

Valneva (NASDAQ:VALN) Coverage Initiated by Analysts at HC Wainwright - Defense World

Aug 20, 2025
pulisher
Aug 18, 2025

Short Interest in Valneva SE Sponsored ADR (NASDAQ:VALN) Expands By 91.2% - Defense World

Aug 18, 2025
pulisher
Aug 15, 2025

Valneva (NASDAQ:VALN) Trading Up 14.3% After Better-Than-Expected Earnings - Defense World

Aug 15, 2025
pulisher
Aug 13, 2025

Valneva (NASDAQ:VALN) Shares Gap Up Following Better-Than-Expected Earnings - Defense World

Aug 13, 2025
pulisher
Aug 13, 2025

Valneva SE earnings beat by $0.22, revenue topped estimates - Investing.com

Aug 13, 2025
pulisher
Aug 12, 2025

Valneva (NASDAQ:VALN) Trading Down 6.7% – Here’s What Happened - Defense World

Aug 12, 2025
pulisher
Aug 10, 2025

Valneva (NASDAQ:VALN) Sets New 1-Year High – Still a Buy? - Defense World

Aug 10, 2025
pulisher
Aug 08, 2025

European ADRs Tick Up As Healthcare And Industrials Shine - Finimize

Aug 08, 2025
pulisher
Jul 24, 2025

Valneva (VALN) Soars 17.4%: Is Further Upside Left in the Stock? - Yahoo Finance

Jul 24, 2025
pulisher
Jun 05, 2025

[Valneva SE] Declaration of shares and voting rights - GlobeNewswire Inc.

Jun 05, 2025
pulisher
May 07, 2025

Valneva SE earnings missed by $0.01, revenue topped estimates - Investing.com

May 07, 2025
pulisher
May 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - Louisiana First News

May 06, 2025
pulisher
Apr 30, 2025

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Louisiana First News

Apr 30, 2025
pulisher
Apr 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - GlobeNewswire Inc.

Apr 25, 2025
pulisher
Apr 22, 2025

Valneva SE Company Investigated by the Portnoy Law Firm - GlobeNewswire

Apr 22, 2025
pulisher
Apr 15, 2025

Valneva shares leap on Brazilian approval of chikungunya vaccine By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 14, 2025

Valneva shares leap on Brazilian approval of chikungunya vaccine - Investing.com Australia

Apr 14, 2025
pulisher
Apr 10, 2025

VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study - MSN

Apr 10, 2025
pulisher
Apr 10, 2025

VALN Doses First Infant With Shigella Vaccine In Mid-Stage Study - Barchart.com

Apr 10, 2025
pulisher
Apr 10, 2025

H.C. Wainwright maintains Buy on Valneva with $17 price target - Investing.com

Apr 10, 2025
pulisher
Apr 09, 2025

Valneva SE ADR’s Banking’s 100-Day Moving Average at 5.61: Will the Stock Break Through? - investchronicle.com

Apr 09, 2025
pulisher
Apr 07, 2025

The Schall Law Probes Valneva Over Vaccine Safety Concerns - Lawyer Monthly

Apr 07, 2025
pulisher
Apr 04, 2025

VALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law Firm - Business Wire

Apr 04, 2025
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):